By Andrea Anderson

ORLANDO, Fla. (GenomeWeb News) – By sequencing 81 tumor exomes, researchers from the Broad Institute and elsewhere have identified a wide range of genes that are each mutated at low frequency in neuroblastoma, attendees of the American Association for Cancer Research annual meeting heard yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.